EMD 3.23% 3.0¢ emyria limited

Ann: Emyria Receives Ethics Approval for MDMA-assisted Therapy, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 411 Posts.
    lightbulb Created with Sketch. 55
    very happy to see the progress here. some details on monetisation would be good, but at the end of the day having these clinics and processes well established will in time only benefit future clinical trials of their proprietary MDMA analogues.
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.